Abusive and Sociopathic Management - Junior Data Analyst Tempus AI Employee Review

1.0
18 Aug 2018
Recommend
CEO approval
Business outlook

Pros

Growing company, strong mission. Free food.

Cons

beware of the Junior Data Analyst position. That team is led by a group of sociopaths that don't understand how to nurture and grow a team of fresh out of school grads. Though many of the obstacles facing the job role are the fault of management, nobody wants to take responsibility and all delays are blamed upon the JDAs for their "inadequate intelligence and lack of care for solving cancer"! They aren't concerned about the high turnover and are more worried about looks than results when it comes to their jobs. The work is monotonous, depressing, and on top of that, full of unwarranted pressure.

Explore other reviews about Tempus AI

5.0
4 July 2026
Recommend
CEO approval
Business outlook

Pros

Good place to work at, very impactful work.

Cons

No cons i can think of tbh.

2.0
12 Mar 2026
Recommend
CEO approval
Business outlook

Pros

As mentioned work is great since it is cancer research and my coworkers are amazing. Immediate leadership managers and Sr. managers are good as well but somewhat unorganised. Work life balance is good also and health insurance as long as you get BCBS PPO with copay otherwise you're screwed paying off deductible.

Cons

Pay is below industry average, and there is essentially no room to negotiate a better raise. Employees are actively discouraged from discussing compensation, and whatever leadership decides is final, there are no exceptions. If you try to escalate concerns or request a conversation with senior leadership, such as a senior director or VP, you’ll quickly find yourself getting the runaround. Leadership prefers to hide behind layers of management rather than engage directly. There is also no clear or transparent path for career advancement. Opportunities technically exist, but they are extremely limited. You can do everything right, receive a top rating of 5 on your annual performance review, and still not be promoted to manager or see any meaningful improvement in compensation. To make matters worse, the billionaire CEO and founder has said things like, “Don’t worry about pay because we’re curing cancer.” Statements like that feel incredibly out of touch when employees are earning $50k–$60k a year and receiving annual raises of only about $2,000. On top of that, equity is almost impossible to obtain. You have to fight for even the possibility of it, because stock or equity compensation is reserved almost exclusively for the C-suite and directors, with virtually nothing available for employees below that level.

2
See reviews by: Helpful|Rating|Date|All